Profil
Neil Kirby is currently a Director at Orphan Technologies Ltd. Previously, he worked as the President & Chief Executive Officer at Edimer Pharmaceuticals, Inc. from 2009 to 2015.
He also held positions as a Director at Genetics Institute LLC, Head-Regulatory Affairs at Biogen MA, Inc., Program Executive at Vertex Pharmaceuticals, Inc., Senior VP-Strategic Product Development at Transkaryotic Therapies, Inc. from 2002 to 2011, and Chief Development Officer at Stromedix, Inc. Dr. Kirby earned a doctorate degree from the University of London.
Anciens postes connus de Neil Kirby
| Sociétés | Poste | Fin |
|---|---|---|
Orphan Technologies Ltd.
Orphan Technologies Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs | Directeur/Membre du Conseil | 14/10/2022 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | - |
Edimer Pharmaceuticals, Inc.
Edimer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products for improving the health and quality of life of families living with XLHED | Directeur Général | - |
Stromedix, Inc.
Stromedix, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs to treat fibrosis and fibrotic organ failure | Corporate Officer/Principal | - |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Directeur/Membre du Conseil | - |
Formation de Neil Kirby
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Develops and manufactures drugs related to immunology, neurobiology and oncology | Health Technology |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets biopharmaceutical products | Commercial Services |
Stromedix, Inc.
Stromedix, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs to treat fibrosis and fibrotic organ failure | Health Technology |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Edimer Pharmaceuticals, Inc.
Edimer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products for improving the health and quality of life of families living with XLHED | Health Technology |
Orphan Technologies Ltd.
Orphan Technologies Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs | Health Technology |
















